Literature DB >> 12429676

A Research Information Sheet for Practices (RISP): a tool to facilitate research participation.

Hilarie Bateman1.   

Abstract

BACKGROUND: Practice teams may receive many requests to become involved in research studies. The information they receive may not necessarily provide the information they need to make a quick and informed decision about participation. Facilitating good decisions about research involvement has potential value for researchers, practitioners and research/development managers.
OBJECTIVE: To develop and pilot a template (RISP) for communicating information about research studies to practice teams.
METHODS: A participatory approach was used to develop the template involving primary care practitioners, researchers and research/development managers. The process of developing and piloting the template was recorded using an action research approach. Data were derived from documentation about policy, notes from participant observation and evaluation questionnaires.
RESULTS: The RISP template was used as a source of reference about practical implications of research and as a means to communicate information about research studies to practice teams. Practice respondents valued its use in enabling members of the practice team to quickly assimilate information about the proposed research study and in providing the basis for a well-informed decision about participation. Its value to record keeping (and to research governance) was anticipated at the planning stage but was not as yet strongly evident in responses from practice.
CONCLUSION: The RISP template has been designed to reflect the concerns of researchers, primary care practitioners and research/development managers. It can contribute to the documentation required in support of research governance.

Entities:  

Mesh:

Year:  2002        PMID: 12429676     DOI: 10.1093/fampra/19.6.691

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  Maximising recruitment and retention of general practices in clinical trials: a case study.

Authors:  Elizabeth Dormandy; Fred Kavalier; Jane Logan; Hilary Harris; Nola Ishmael; Theresa M Marteau
Journal:  Br J Gen Pract       Date:  2008-11       Impact factor: 5.386

2.  Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.

Authors:  Elizabeth Dormandy; Martin Gulliford; Stirling Bryan; Tracy E Roberts; Michael Calnan; Karl Atkin; Jonathan Karnon; Jane Logan; Fred Kavalier; Hilary J Harris; Tracey A Johnston; Elizabeth N Anionwu; Vicki Tsianakas; Patricia Jones; Theresa M Marteau
Journal:  BMJ       Date:  2010-10-05

3.  The ProActive trial protocol - a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766].

Authors:  Kate Williams; A Toby Prevost; Simon Griffin; Wendy Hardeman; William Hollingworth; David Spiegelhalter; Stephen Sutton; Ulf Ekelund; Nicholas Wareham; Ann Louise Kinmonth
Journal:  BMC Public Health       Date:  2004-10-18       Impact factor: 3.295

4.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

5.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

6.  Gaining information about home visits in primary care: methodological issues from a feasibility study.

Authors:  Karen Voigt; Stephanie Taché; Andreas Klement; Thomas Fankhaenel; Stefan Bojanowski; Antje Bergmann
Journal:  BMC Fam Pract       Date:  2014-05-06       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.